Matches in Wikidata for { <http://www.wikidata.org/entity/Q93198517> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q93198517 description "article scientifique publié en 2019" @default.
- Q93198517 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q93198517 description "scientific article published on 30 August 2019" @default.
- Q93198517 description "wetenschappelijk artikel" @default.
- Q93198517 description "наукова стаття, опублікована 30 серпня 2019" @default.
- Q93198517 name "Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing piperazine as inhibitors of PI3Kα" @default.
- Q93198517 name "Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing piperazine as inhibitors of PI3Kα" @default.
- Q93198517 type Item @default.
- Q93198517 label "Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing piperazine as inhibitors of PI3Kα" @default.
- Q93198517 label "Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing piperazine as inhibitors of PI3Kα" @default.
- Q93198517 prefLabel "Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing piperazine as inhibitors of PI3Kα" @default.
- Q93198517 prefLabel "Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing piperazine as inhibitors of PI3Kα" @default.
- Q93198517 P1433 Q93198517-40E01909-B255-4D8A-A6C2-DC0086D9CB25 @default.
- Q93198517 P1476 Q93198517-DF46BCF6-304A-4DEF-9317-F51DABD09C83 @default.
- Q93198517 P2093 Q93198517-682E57AE-2DD9-49C4-9FAB-0F3E412E73B9 @default.
- Q93198517 P2093 Q93198517-741518ED-6370-4B07-AD52-D50FFA036ECC @default.
- Q93198517 P2093 Q93198517-8A4A45C0-F6B4-4048-9B9C-CF6BCAB7B185 @default.
- Q93198517 P2093 Q93198517-BF21C077-51FE-4ACE-86FA-F386CF2FF8CA @default.
- Q93198517 P2093 Q93198517-C2575E2D-B7E7-42D3-93F9-2553B7439E5D @default.
- Q93198517 P2093 Q93198517-C74A9DBB-4AD2-4F60-8C59-7DFC2F40660A @default.
- Q93198517 P2093 Q93198517-EDD3A253-96ED-4228-B84B-B1083B246797 @default.
- Q93198517 P2093 Q93198517-F5B6F1F1-A335-472B-8EC3-F28672C57FC3 @default.
- Q93198517 P304 Q93198517-D82207FD-826F-4F75-9956-56D9EF0DDDC7 @default.
- Q93198517 P31 Q93198517-DC2C5532-31D3-4AE3-A284-568DC0C1FF25 @default.
- Q93198517 P356 Q93198517-B1D8E303-EF5C-472D-B5DC-2455BE2953AE @default.
- Q93198517 P478 Q93198517-0DB10B51-FEE4-4F6C-97F8-4A6A7D1B0053 @default.
- Q93198517 P577 Q93198517-891F3863-6F3F-4E35-8A7D-34A2C1FEBA27 @default.
- Q93198517 P698 Q93198517-AF2B87A9-77FD-49FE-A71D-6673DC033357 @default.
- Q93198517 P356 J.BIOORG.2019.103238 @default.
- Q93198517 P698 31499259 @default.
- Q93198517 P1433 Q2904198 @default.
- Q93198517 P1476 "Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing piperazine as inhibitors of PI3Kα" @default.
- Q93198517 P2093 "Fang Qiao" @default.
- Q93198517 P2093 "Hai-Liang Zhu" @default.
- Q93198517 P2093 "Shao Sha" @default.
- Q93198517 P2093 "She-Feng Wang" @default.
- Q93198517 P2093 "Xun Wu" @default.
- Q93198517 P2093 "Yang Zhou" @default.
- Q93198517 P2093 "Yong Yin" @default.
- Q93198517 P2093 "Zhong-Cheng Song" @default.
- Q93198517 P304 "103238" @default.
- Q93198517 P31 Q13442814 @default.
- Q93198517 P356 "10.1016/J.BIOORG.2019.103238" @default.
- Q93198517 P478 "92" @default.
- Q93198517 P577 "2019-08-30T00:00:00Z" @default.
- Q93198517 P698 "31499259" @default.